Rate and extent of oxaliplatin absorption after hyperthermic intraperitoneal administration in peritoneal carcinomatosis patients

被引：0
|
作者：
Carlos Pérez-Ruixo
José E. Peris
Vanesa Escudero-Ortiz
Pedro Bretcha-Boix
José Farré-Alegre
Juan José Pérez-Ruixo
Belén Valenzuela
机构：
[1] University of Valencia,Pharmacy and Pharmaceutical Technology Department
[2] Hospital Quirón Torrevieja,Platform of Oncology
[3] AMGEN,Pharmacokinetics and Drug Metabolism
[4] UCAM Catholic University of San Antonio,Cathedra of Multidisciplinary Oncology
[5] Hospital Quiron Torrevieja,Personalized Pharmacotherapy Unit, Platform of Oncology
[6] Consulting Projects for Research,undefined
来源：
Cancer Chemotherapy and Pharmacology | 2014年 / 73卷
关键词：
Oxaliplatin bioavailability; Peritoneal carcinomatosis; Pharmacokinetics; NONMEM; Hyperthermic intraperitoneal chemotherapy; Cytoreductive surgery;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1009 / 1020
页数：11
相关论文
共 50 条
  • [21] Intraperitoneal chemohyperthermia (IPCH) with oxaliplatin for patients with colorectal peritoneal carcinomatosis.
    Yongqian, S
    Lingxiang, L
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 287S - 287S
  • [22] Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis
    Khan, Hadi M.
    Hanif, Hamza
    JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2022, 32 (02): : 259 - 261
  • [23] Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy in peritoneal carcinomatosis
    Nesher, Eviatar
    Greenberg, Ron
    Avital, Shmuel
    Skornick, Yehuda
    Schneebaunn, Schlomo
    ISRAEL MEDICAL ASSOCIATION JOURNAL, 2007, 9 (11): : 787 - 790
  • [24] Hyperthermic intraperitoneal chemotherapy with oxaliplatin for peritoneal carcinomatosis arising from appendix:: Preliminary results of a survival analysis
    Marcotte, Eric
    Sideris, Lucas
    Drolet, Pierre
    Mitchell, Andrew
    Frenette, Suzanne
    Leblanc, Guy
    Leclerc, Yves E.
    Dube, Pierre
    ANNALS OF SURGICAL ONCOLOGY, 2008, 15 (10) : 2701 - 2708
  • [25] Erratum to: Pharmacokinetic and Pharmacodynamic Analysis of Hyperthermic Intraperitoneal Oxaliplatin-Induced Neutropenia in Subjects with Peritoneal Carcinomatosis
    Belén Valenzuela
    Ricardo Nalda-Molina
    Pere Bretcha-Boix
    Vanesa Escudero-Ortíz
    Maria José Duart
    Vicente Carbonell
    Manuel Sureda
    José Pascual Rebollo
    Josep Farré
    Antonio Brugarolas
    Juan Pérez-Ruixo
    The AAPS Journal, 2011, 13 : 318 - 318
  • [26] Mortality and Morbidity after Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis
    Saxena, Akshat
    Morris, David L.
    VISZERALMEDIZIN, 2013, 29 (04): : 231 - 234
  • [27] Hyperthermic Intraperitoneal Chemotherapy with Oxaliplatin for Peritoneal Carcinomatosis Arising from Appendix: Preliminary Results of a Survival Analysis
    Eric Marcotte
    Lucas Sideris
    Pierre Drolet
    Andrew Mitchell
    Suzanne Frenette
    Guy Leblanc
    Yves E. Leclerc
    Pierre Dubé
    Annals of Surgical Oncology, 2008, 15 : 2701 - 2708
  • [28] Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy With Oxaliplatin for Peritoneal Carcinomatosis Arising From Colorectal Cancer
    Gervais, Mai-Kim
    Dube, Pierre
    McConnell, Yarrow
    Drolet, Pierre
    Mitchell, Andrew
    Sideris, Lucas
    JOURNAL OF SURGICAL ONCOLOGY, 2013, 108 (07) : 438 - 443
  • [29] Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with colon cancer and peritoneal carcinomatosis
    Glockzin, G.
    Ghali, N.
    Schlitt, H. J.
    Piso, P.
    ANNALS OF SURGICAL ONCOLOGY, 2008, 15 : 93 - 93
  • [30] Predictors of Severe Morbidity After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Patients With Colorectal Peritoneal Carcinomatosis
    Geert A. Simkens
    Thijs R. van Oudheusden
    Misha D. Luyer
    Simon W. Nienhuijs
    Grard A. Nieuwenhuijzen
    Harm J. Rutten
    Ignace H. de Hingh
    Annals of Surgical Oncology, 2016, 23 : 833 - 841
12345